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INTRODUCTION
Chronic morphine administration leads both to alterations in µ-opioid receptor (MOPr) signaling and the development of complex adaptations in the neuronal circuitry involved in the characteristic responses to opioids to produce opioid tolerance, dependence and withdrawal (Williams et al., 2001; Christie, 2008) . However, it is unclear whether common molecular mechanisms are involved in both tolerance and dependence. -arrestin-2 (arr-2, arrestin3) is a multifunctional protein that participates in G protein coupled receptor (GPCR) signaling and is involved in the rapid attenuation of GPCR signaling and mechanisms of opioid tolerance (Williams et al., 2013) . It has been reported that mice lacking arr-2 have an exaggerated acute antinociceptive response to morphine and display reduced tolerance to these antinociceptive effects (Bohn et al., 1999; Bohn et al., 2000; Bohn et al., 2002; . arr-2 knockout mice display an unchanged (Bohn et al., 2000) or slightly reduced sensitivity to naloxone-precipitated withdrawal after chronic morphine treatment. Physiological and biochemical studies of MOPr sensitivity in untreated arr-2 knockout mice have yielded conflicting results. Studies using GTPS assays have generally reported enhanced basal MOPr sensitivity in arr-2 knockouts (Bohn et al., 1999; Bohn et al., 2000; Bohn et al., 2002) but electrophysiological studies have found reduced sensitivity (Walwyn et al., 2007; Dang et al., 2009; Dang et al., 2011) . Consistent with behavioural studies, electrophysiological studies have confirmed blunted cellular tolerance in locus coeruleus neurons from arr-2 knockout mice but whether these neurons are involved in analgesic tolerance is unclear (Dang et al., 2011) .
The midbrain periaqueductal grey (PAG) mediates important aspects of opioid antinociception, tolerance and withdrawal, although adaptations to chronic morphine treatment are diverse and not restricted to this region (Williams et al., 2001; Morgan et al., 2006; Christie, 2008) . We have previously described a series of cellular adaptations in the PAG following chronic morphine treatment with a sustained release morphine preparation. These include enhanced release of GABA driven by increased activity of the GABA transporter GAT-1 (Bagley et al., 2005b; Bagley et al., 2011) , a switch in the mechanism by which µ-opioids inhibit GABA release in the PAG (Ingram et al., 1998; Hack et al., 2003) and a decrease in the efficacy of µ-opioids to inhibit voltage gated calcium channel currents (ICa, Bagley et al., 2005a) . We have shown that increased GAT-1 activity in the PAG is largely responsible for centrally mediated opioid withdrawal behaviours (Bagley et al., 2011) . The role of other adaptations in withdrawal is less clear. In this study we examined whether the presence of arr-2 was important for chronic morphine-induced changes to MOPr coupling, and GAT-1 activity. We found that untreated mice lacking arr-2 respond to morphine indistinguishably from wild-type animals, and that whilst changes in GAT-1 activity are maintained in arr-2 knockout animals, the reduced inhibition of ICa seen in chronic morphine treated wild-type mice is not seen in arr-2 knockout animals. Thus cellular tolerance is abolished but an important cellular adaptation responsible for opioid withdrawal, opioid modulation of the enhanced GAT-1 transporter current, is maintained.
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METHODS
All experiments were performed on male mice (n = 40) according to protocols approved by the RNSH Animal Ethics Committee, which complies with the National Health and Medical
Research Council Australian code of practice for the care and use of animals for scientific purposes. All experiments were performed on routinely genotyped, 4-8 weeks old βarr-2 knockout mice and wild type controls on a C57Bl6 background provided by Drs Lefkowitz and Caron (Duke University, see Bohn et al., 2000) . We maintained the colony as heterozygote -xheterozygote crosses for at least eight generations prior to commencement of this study. βarr-2 knockout and wildtype animals used in the present study were genotyped offspring from these multiple heterozygote -x-heterozygote crosses. Mice were kept in twelve-hour day-night cycle in a low background noise room ventilated at constant temperature of 21-22 o C. Animals were housed in groups of up to six with environmental enrichment.
Chronic morphine treatment
Chronic morphine treatment was performed as described previously (Bagley et al., 2005a; 2005b) . Briefly, mice were administered a series of 3 subcutaneous injections of morphine base (300 mg kg -1 ) in a sustained release emulsion on alternate days over a 5 day period. The sustained release preparation consisted of 50 mg of morphine base suspended in 1 ml of emulsion (0.1 ml of Arlacel A (mannide monooleate), 0.4 ml of light liquid paraffin and 0.5 ml of 0.9 % w v -1 NaCl). Injections of warmed suspension were made under light isoflurane (4% in air)
anaesthesia. Vehicle mice were injected with suspension lacking morphine. Vehicle and morphine treatments were performed in parallel. Animals were used on day 6 or 7.
Tissue Preparation
Mice (at least 6 weeks old for dissociated cells, 4 to 6 weeks old for slice recordings) were anaesthetized with isoflurane and killed by decapitation. Coronal midbrain slices (220-250 µm thick for slice recording, 350 µm thick for dissociation) containing the periaqueductal grey were cut with a vibratome in ice cold physiological saline (ACSF) of composition (mM) NaCl 126, KCl 2.5, MgCl 2 1.2, CaCl 2 2.4, NaH 2 PO 4 1.2, NaHCO 3 , 24 and glucose 11; gassed with 95% O 2 /5% CO 2 and stored for 30 min at 35 o C. Cells were dissociated as previously described (Connor et al., 1999b) . Briefly, slices were transferred to a dissociation buffer of composition (mM) Na 2 SO 4 82, K 2 SO4 30, HEPES 10, MgCl 2 5, glucose 10, containing 20 units ml -1 papain, pH 7.3 and incubated for 2 minutes at 35 o C. The slices were then placed in fresh dissociation buffer containing 1 mg ml -1 bovine serum albumin (BSA) and 1 mg ml -1 trypsin inhibitor and the periaqueductal grey region was sub-dissected from each slice with a fine tungsten wire. Cells were dissociated from the slices by gentle trituration, plated onto plastic culture dishes and kept at room temperature in dissociation buffer. Buffers for cell dissociation did not contain morphine, so isolated cells were in a withdrawn state for the duration of the experiments.
Brain slice Electrophysiology
After cutting, PAG slices were maintained at 34 o C in a submerged chamber containing ACSF and were later transferred to a chamber superfused at 2 ml/min with ACSF (34 o C) for recording.
Brain slices from both morphine-dependent and vehicle treated mice were maintained in vitro in ACSF containing 5 µM morphine. Slices were spontaneously withdrawn by incubation in morphine free ACSF for at least 1 hr before an experiment. PAG neurons were visualized using infra-red Nomarski optics and recordings made from neurons in the ventrolateral region of the PAG (Bagley et al., 2005b) . Perforated patch-clamp recordings were made using electrodes (4 -5 M) filled with (mM): K acetate 120; HEPES 40: EGTA 10; MgCl2 5; with Pluronic F-127 0.25 mg/ml; amphotericin B 0.12 mg/ml (pH 7.2, 290 mosmol l -1 ). A liquid junction potential for K acetate internal solution of -8mV was corrected. Series resistance (< 25 M) was compensated by 80% and continuously monitored. During perforated patch recordings, currents were recorded using an Axopatch 200A amplifier (Axon Instruments), digitized, filtered (at 2 kHz) and then acquired (sampling at 10 kHz) in pClamp (Axon Instruments) or using Axograph Acquisition software (Axon Instruments). Drugs were added directly to the ACSF and applied by switching the bath superfusion to the ACSF containing the drugs.
Dissociated PAG neuron electrophysiology
Recordings of currents through Ca 2+ channels (ICa) were made using standard whole cell patch clamp techniques (Hamill et al., 1981) at room temperature (20-24 o C), as previously described (Connor et al., 1999b) . Dishes of cells were superfused with a HBS of composition ( Recordings were made between 30 minutes and up to 6 hours after dissociation. ICa amplitude was similar in cells recorded first (191 ± 14 pA/pF) and last (184 ± 12 pA, P = 0.74, n=33 each) on any day.
Statistical Analysis
Concentration response data from different days was pooled and data from each condition compared with a 2 way ANOVA. Where there was a significant variation produced by treatment, the responses at each concentration were compared using a Bonferroni post hoc test corrected for multiple comparisons. The proportion of DAMGO-responding cells in each group of cells was compared using a 2 test. Other comparisons were made using unpaired Student's T-tests.
Statistical tests were performed in Graphpad Prism (www.graphpad.com).
Drugs and Chemicals
Buffer salts were from BDH Australia or Sigma Australia. Papain was from Worthington Biochemical Corporation (Freehold, NJ, USA). All other chemicals were from Sigma Australia except the following: Met-enkephalin and DAMGO (Tyr-D-Ala-Gly-N-Me-Phe-Gly-ol enkephalin) were from Auspep (Melbourne, Australia).
Baclofen was from Research
Biochemicals International (Natick, MA, USA). CNQX was from Tocris Cookson (Bristol, UK).
Tetrodotoxin was from Alomone (Israel). Morphine base and morphine hydrochloride were from Glaxo UK. CGP55845 was a gift from Ciba Ltd (Basel, Switzerland).
RESULTS
The µ-opioid agonist DAMGO rapidly and reversibly inhibits ICa in most mouse PAG neurons, examples of this inhibition in neurons from vehicle treated and chronic morphine treated arr-2 knockout mice are shown in Figure 1 . There was no difference in the potency or efficacy of the µ-opioid agonist DAMGO to inhibit ICa in PAG neurons between untreated wild-type and arr-2 knockout mice ( Figure 2A , 2-way ANOVA comparing DAMGO inhibition in cells from naïve animals of either genotype showed a significant interaction for concentration (P < 0.001), but no significant interaction for genotype (P=0.60)). DAMGO inhibited ICa in cells from wild-type mice with an EC50 of 310 nM (pEC50 6.51 ± 0.15), and maximum inhibition of 36 ± 3%, in cells from arr-2 knockout animals the EC50 was 300 nM (pEC50 6.52 ± 0.05), the maximum inhibition 34 ± 1 %. We previously reported that chronic morphine treatment produces a decrease in the effectiveness of µ-opioids to inhibit ICa in mouse periaqueductal grey neurons (Bagley et al., 2005a) and these effects were reproduced in the arr-2 wild-type mice ( Figure 2B , 2-way ANOVA comparing DAMGO inhibition in cells from wildtype vehicle and CMT animals showed a significant interaction for concentration (P < 0.001), and treatment (P < 0.001). As previously reported (Bagley et al., 2005a) , the MOPr agonist DAMGO was also less effective at inhibiting ICa in PAG neurons from chronic morphine treated wild-type mice than in neurons from vehicle treated animals, with the maximum inhibition of ICa reduced from 34 ± 2 % in cells from vehicle treated mice to 23 ± 2 % in chronic morphine treated cells (P = 0.009, Bonferroni post hoc test corrected for multiple comparisons; Figure 2B ). However, the reduction in the maximal effect of DAMGO produced by chronic morphine treatment was not observed in PAG neurons from arr-2 knockout mice ( Figure 2C ; 2-way ANOVA comparing DAMGO inhibition in cells from arr-2 knockout vehicle and CMT animals showed a significant interaction for concentration (P < 0.001), but not treatment (P = 0.571)). DAMGO inhibited ICa in vehicle treated arr-2 knockout mice by a maximum of 28 ± 1 % and in neurons from chronic morphine treated mice to 31 ± 2 %. DAMGO inhibited ICa in a similar proportion of PAG neurons from untreated or vehicle treated mice in each genotype (70 %, 2, P = 0.8) and this proportion was not significantly changed by chronic morphine treatment (2, P = 0.53 in wild-type mice, 2, P = 0.49 in arr-2 knockouts). ICa density did not differ between naïve animals of either genotype (wt, 196 ± 12 pA/pF, n=30; arr-2 knockouts 174 ± 16 pA/pF, n= 19, P = 0.29), nor did it differ between cells from treated animals ( Figure 3C ,D). The inhibition of ICa by the GABAB agonist baclofen was also similar in each treatment group. (Figure 1 , Figure 3A , B).
In PAG neurons, withdrawal from chronic morphine treatment stimulates a protein kinase Adependent increase of the GAT-1 cation conducatance. The increased GAT-1 activity is sensitive to opioid inhibition and therefore during opioid withdrawal it can be detected by changes in the MENK current reversal potential. When MENK is reducing the GAT-1 cation conductance and increasing the GIRK conductance the MENK reversal potential will be much more negative than Ek (Bagley et al., 2005) . Superfusion of met-enkephalin (MENK) produced an outward current in PAG neurons voltage clamped at -56 mV in slices from both vehicle-and chronic morphinetreated arr-2 knockout mice (Figure 4 ). In neurons from vehicle treated mice the ME current reversed polarity at a potential of -100 ± 5 mV, close to the K equilibrium potential in these conditions (-103 mV), as we have previously reported in wild-type mice (Bagley et al., 2005; Bagley et al., 2011) . In neurons from chronic morphine treated arr-2 knockout mice, the MENK-induced current reversed in only 3 of 7 cells. In the neurons where the MENK current 13 did not reverse polarity at the most negative potential tested, the reversal potentials was assigned a value of -136 mV, a conservative approach we adopted in previous studies to deal with technical inability to determine extremely negative reversal potentials (Bagley et al., 2005; Bagley et al., 2011) . The nominal reversal potential for the 7 cells was -130 ± 3 mV. Subsequent superfusion of MENK in the presence of the GAT-1 inhibitor, NO-711, resulted in currents that reversed polarity at significantly more positive potentials than in the absence of NO-711 (P < 0.05), and close to the value for MENK currents in neurons from vehicle treated mice (Figure 4 ).
DISCUSSION
In this study we have found that the presence of arr-2 is required for the reduction in acute MOPr signaling seen in PAG neurons following chronic morphine treatment, but that it is not required for the expression of increased GAT-1 activity during withdrawal. These results in single neurons relevant for the antinociceptive actions of morphine are consistent with previous findings of lack of cellular tolerance in locus coeruleus neurons from arr-2 knockout mice (Dang et al. 2011; Quillinan et al., 2011) and establish for the first time that a cellular adaptation in PAG neurons that contributes to opioid withdrawal behaviour (Bagley et al., 2005b; Bagley et al., 2011) is not disrupted by the knockout. The findings are consistent with behavioural studies in arr-2 knockout mice that reported reduced tolerance to morphine (Bohn et al., 2000; Bohn et al., 2002 ) but a normal (Bohn et al. 2000) or partially blunted naloxoneprecipitated withdrawal response. It remains possible that arr-2-related adaptations in populations of neurons other than PAG contributing to opioid withdrawal contribute to the blunted withdrawal response reported by .
Inhibition of ICa in PAG neurons by activation of MOPr is mediated via  subunits of the Gi/Go proteins activated by the receptor (Williams et al., 2001) and represents a direct and rapid measure of receptor/G protein coupling in an intact cell. A reduction in G-protein  subunitmediated MOPr coupling in animals treated with sustained release morphine has been reported in locus coeruleus (Christie et al., 1987; Connor et al., 1999a; Dang et al., 2011) , sensory neurons (Johnson et al., 2006) as well as PAG (Bagley et al., 2005a) , so it appears to be a common cellular response to continuous morphine treatment. The maintenance of unperturbed MOPr signaling in single PAG neurons from chronically morphine treated arr-2 knockout animals is also consistent with data showing absence of morphine tolerance to the reduction in MOPr stimulated GTPS binding to membranes from the brainstem of arr-2 knockout mice (Bohn et al., 2000) .
The present finding that sensitivity of inhibition of ICa by MOPr agonist was not affected by arr-2 knockout in PAG neurons is comparable to the modestly blunted coupling to inwardly rectifying K-currents in locus coeruleus neurons (Dang et al., 2009; Dang et al., 2011) and inhibition of ICa in sensory neurons (Walwyn et al., 2007) . By contrast, using GTPS assays to assess agonist activated MOPr function in untreated arr-2 knockouts, opioid sensitivity was reported to be profoundly enhanced in PAG (Bohn et al., 1999) and brainstem (Bohn et al. 2000) , and less so spinal cord (Bohn et al., 2002) membranes. There is no obvious explanation for the differences between data obtained with electrophysiology and GTPS binding, particularly in PAG, other than the very different nature of the assays. Which assay is a more faithful reflection of MOPr function is uncertain, however, electrophysiological assays are carried out in relatively intact cells in real time and so any issues of acute receptor desensitization or re-organization of signaling complexes during membrane preparation are minimized. It is also possible that the results differ because the experimental approaches reflect MOPr activity in different cellular compartments. Modulation of ICa by MOPr is assayed, of course, only in the cell body whereas the GTPS assay reflects a composite of membranes from cell body, dendritic and nerve terminal compartments. The possibility that regulation of MOPr function differs between soma/dendrites and nerve terminals, in neurons, including PAG neurons, has been raised by several studies (Haberstock-Debic et al., 2005; Fyfe et al., 2010; Pennock et al., 2012) .
A cellular hallmark of withdrawal in PAG is protein kinase A-dependent increases in GAT-1 currents (Bagley et al., 2005b; Bagley et al., 2011) . PAG neurons recorded in brain slices from chronically morphine treated arr-2 knockout mice display increased GAT-1 currents during withdrawal as previously reported. These results are consistent with those of Bohn et al. (2000) who showed that the characteristic withdrawal-induced elevations in cAMP observed in chronically morphine treated brain tissue was preserved in arr-2 knockouts.
In the present study we found no difference in the potency of DAMGO to inhibit ICa in PAG neurons from untreated animals. Similarly, MOPr coupling to ion channels in neurons from arr-2 knockout animals has consistently been found to be similar to or even somewhat reduced from that of wildtypes (Walwyn et al., 2007; Dang et al, 2009 ). By contrast, behavioural studies of arr-2 knockout animals observed enhanced anti-nociceptive responses to morphine (Bohn et al., 1999; Mittal et al., 2011) .
The role of arr-2 in acute MOPr regulation has been established most firmly in vitro, with many studies reporting that altering arr-2 levels promoted or inhibited MOPr trafficking and signaling.
In general, morphine was less effective at mediating arrestin-dependent processes than more efficacious agonist such as met-enkephalin, DAMGO or etorphine, although this does not mean that morphine is ineffective at producing reductions in receptor signaling (e.g. induced receptor desensitization and internalization in the locus coeruleus of arr-2 knockout mice suggests that morphine may also recruit the ERK pathway (Arttamangkul et al., 2008) .
Studying morphine-induced adaptations is important because morphine and closely related analogs are the still among the most widely prescribed opioid analgesics and the morphine prodrug heroin is also one of the most widely abused opioids. However, it should be borne in mind that arr-2 is likely to interact with many different G protein coupled receptors and ion channels whose activity also modifies the functional outputs of opioid-sensitive neurons and circuits. Thus any changes in mouse behaviour associated with morphine exposure are likely to also reflect 18 contributions from these other systems. Deletion of arr-2 can in some circumstances modulate the cellular response to acute and chronic morphine (this study, Dang et al., 2011; Walwyn et al., 2007) , but the maintenance of crucial cellular adaptations in morphine-tolerant arr-2 knockout animals indicates that arr-2 interaction with MOPrs are not crucial for the development of morphine dependence.
Figure Legends s.e.m. of at least 6 cells, curves were fitted to the pooled data. DAMGO potency and maximal effect did not differ between untreated mice of either genotype, while the maximum effect of DAMGO was reduced in neurons from chronically morphine treated wildtype but nor βarr-2 knockout animals (P < 0.05, 2 way ANOVA followed by Bonferroni post hoc test). 
